BJA Advance Access published online on June 15, 2007
British Journal of Anaesthesia, doi:10.1093/bja/aem158
Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery
1 Health Services Research Unit
2 Department of Clinical Biochemistry
3 Department of Surgery
4 Department of Cardiology, University of Aberdeen and Aberdeen Royal Infirmary, Aberdeen AB25 2ZD, UK
* Corresponding author: E-mail: b.h.cuthbertson{at}abdn.ac.uk
Background: B-type natriuretic peptide (BNP) levels predict cardiovascular risk in several settings. We hypothesized that they would identify individuals at increased risk of early cardiac complications after major non-cardiac surgery. The current study tests this hypothesis.
Methods: Two hundred and four patients undergoing major non-cardiac surgery were studied. The primary end-point was the development of acute myocardial injury [defined as cardiac troponin I (cTnI) level >0.32 ng ml–1] or death in the 3 days after surgery.
Results: Preoperative BNP levels were raised in patients who died or suffered perioperative myocardial injury (median 52.2 vs 22.2 pg ml–1, P = 0.01) and BNP predicted this outcome with an area under the receiver operating characteristic curve of 0.72 [95% confidence interval (CI) 0.59–0.86, P = 0.01]. A preoperative BNP value >40 pg ml–1 was associated with an increased risk of death or perioperative myocardial injury [odds ratio (OR) 6.8, 95% CI 1.8–25.9, P = 0.003], and remained independently predictive after correction for the Revised Cardiac Risk Index. Preoperative BNP levels were higher in patients who exhibited new onset atrial fibrillation or ST/T-wave changes on their postoperative ECG (median 50.5 vs 22.5 pg litre–1, P = 0.01). They were also higher in patients who had either elevation of cTnI >0.32 ng ml–1 or postoperative ECG abnormalities (median 50.4 vs 21.5 pg ml–1, P<0.001).
Conclusions: In the setting of major non-cardiac surgery, preoperative BNP levels are higher in patients who experience perioperative death and myocardial injury. Larger studies are required to confirm these data and to clarify what BNP levels may add to existing methods of risk stratification.
Keywords: complications, myocardial infarction; risk; surgery, non-cardiac
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Authors/Task Force Members, D. Poldermans, J. J. Bax, E. Boersma, S. De Hert, E. Eeckhout, G. Fowkes, B. Gorenek, M. G. Hennerici, B. Iung, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA) Eur. Heart J., November 2, 2009; 30(22): 2769 - 2812. [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Cuthbertson, B. L. Croal, D. Rae, P. H. Gibson, J. D. McNeilly, R. R. Jeffrey, W. C. Smith, G. J. Prescott, K. G. Buchan, H. El-Shafei, et al. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study Br. J. Anaesth., November 1, 2009; 103(5): 647 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Karthikeyan, R. A. Moncur, O. Levine, D. Heels-Ansdell, M. T.V. Chan, P. Alonso-Coello, S. Yusuf, D. Sessler, J. C. Villar, O. Berwanger, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J. Am. Coll. Cardiol., October 20, 2009; 54(17): 1599 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oscarsson, M. Fredrikson, M. Sorliden, S. Anskar, and C. Eintrei N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery Br. J. Anaesth., August 1, 2009; 103(2): 206 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bolliger, M. D. Seeberger, G. A. L. Lurati Buse, P. Christen, B. Rupinski, L. Gurke, and M. Filipovic A Preliminary Report on the Prognostic Significance of Preoperative Brain Natriuretic Peptide and Postoperative Cardiac Troponin in Patients Undergoing Major Vascular Surgery Anesth. Analg., April 1, 2009; 108(4): 1069 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Mueller, B. Dieplinger, W. Poelz, G. Endler, O. F. Wagner, and M. Haltmayer Amino-Terminal Pro-B-Type Natriuretic Peptide as Predictor of Mortality in Patients with Symptomatic Peripheral Arterial Disease: 5-Year Follow-Up Data from the Linz Peripheral Arterial Disease Study Clin. Chem., January 1, 2009; 55(1): 68 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fujita Significance of Circulating B-Type Natriuretic Peptide in Sepsis Arch Surg, October 1, 2008; 143(10): 1021 - 1022. [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Mittnacht, M. Fanshawe, and S. Konstadt Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2008; 12(1): 33 - 59. [Abstract] [PDF]
|
|
|
|
|
|
E. Mahla, M. Vicenzi, W. Toller, B. H. Cuthbertson, and (on behalf of the authors) B-type natriuretic peptide in high-risk major surgery patients Br. J. Anaesth., November 1, 2007; 99(5): 746 - 747. [Full Text] [PDF]
|
|
|
|
|
|
J. W. Sear and G. Howard-Alpe Preoperative plasma BNP concentrations: do they improve our care of high-risk non-cardiac surgical patients? Br. J. Anaesth., August 1, 2007; 99(2): 151 - 154. [Full Text] [PDF]
|
|
E-letters:
Read all E-letters
- Predictive value of BNP in major non-cardiac surgery
- Elisabeth Mahla, et al.
- British Journal of Anaesthesia, 14 Aug 2007 [Full text]
- BNP in high risk major surgery patients
- Brian Cuthbertson
- British Journal of Anaesthesia, 14 Aug 2007 [Full text]